NASDAQ: TVGN
Tevogen Bio Holdings Inc Earnings Dates, Reports, Calls

Tevogen Bio Holdings earnings were -$5.1M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest TVGN earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$5.9M, down 2.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TVGN reported annual earnings of -$60.5M, with 174.4% growth.

TVGN earnings history

Current Revenue
$0.0
Current Earnings
-$5.1M
Current Profit Margin
0%

TVGN Return on Equity

Insufficient data to display

TVGN Return on Assets

Current Company
-124.1%
Current Industry
1.3%
TVGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TVGN announces earnings.

TVGN Return on Capital Employed

Current Company
75.48%
Current Industry
14.3%

TVGN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TVGN-$4.22M-$5.11MN/A-$0.13
IMMP-$28.46M-$28.48MN/A-$0.24
GOSS-$52.24M-$71.65MN/A-$0.26
RZLT-$70.59M-$71.13MN/A-$1.22
OLMA-$121.13M-$122.68MN/A-$2.18

Tevogen Bio Holdings Earnings Reports & History FAQ

What were Tevogen Bio Holdings's earnings last quarter?

Tevogen Bio Holdings (NASDAQ: TVGN) reported Q3 2024 earnings per share (EPS) of -$0.03, up 0% year over year. Total TVGN earnings for the quarter were -$5.91 million. In the same quarter last year, Tevogen Bio Holdings's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Tevogen Bio Holdings stock.

Is Tevogen Bio Holdings profitable or losing money?

As of the last Tevogen Bio Holdings earnings report, Tevogen Bio Holdings is currently losing money. Tevogen Bio Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$5.11 million, a 91.83% decrease year over year.

What was TVGN's earnings growth in the past year?

As of Tevogen Bio Holdings's earnings date in Q1 2025, Tevogen Bio Holdings's earnings has grown year over year. TVGN earnings in the past year totalled -$5.11 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.